Particulate matter in injections according to USP <788> and Ph. Eur. 2.9.19
Quantification of subvisible particulate matter in injectable and parenteral solutions according to USP <788> or the harmonized method Ph. Eur. 2.9.19. Testing is commonly performed as part of batch release and compliance verification against particle count limits.
We offer both methods specified in USP <788> and Ph. Eur. 2.9.19:
Method 1: Light obscuration particle count
Method 2: Microscopic particle count
Method 1 is generally preferred unless the sample is not suited to it, for example, because of high viscosity, opacity, or a tendency to form gas bubbles. In some cases, it may be necessary to perform both tests (e.g., when Method 1 results are borderline).
Results are reported as particle counts by size range per container or per specified sampling unit. A comparison against the applicable pharmacopoeial limits or customer-defined specifications is also provided.
- Suitable sample matrices
- Parenteral pharmaceutical products intended for intramuscular, subcutaneous, or intravenous administration; sterilized water for injections
- Required sample quantity
- 3-5 pieces/material
- Typical turnaround time
- 5 – 6 weeks after receiving the samples
- Available quality systems
- Accredited testing laboratory, GMP test method
- Standard
- Method expert
Ask for an offer
Fill in the form, and we'll reply in one business day.
Have questions or need help? Email us at info@measurlabs.com or call our sales team.
